Dr. Harman Sekhon, MD, MSc, PhD, FCAP
After graduating from medical school, Dr. Sekhon obtained MSc and PhD in Pathology, Faculty of Medicine, at the University of British Columbia, Vancouver (UBC), Canada. Thereafter, he did Post-doctoral Fellowship at the UBC and subsequently joined as a Research Scholar at the Tulane University, New Orleans, Louisiana and holds a US patent for novel in utero gene therapy.
He completed combined Anatomic Pathology/Clinical Pathology residency training at the Oregon Health Sciences University (OHSU), Portland, OR, USA and went on to do Cytopathology Fellowship at the University of Washington, Seattle, Washington followed by Surgical Pathology Fellowship at OHSU, Portland. After working in the United States, he joined Ottawa Hospital (TOH) in 2008, served as a Director of Cytopathology and promoted to Full Professor at the University of Ottawa. He is currently EORLA Regional Director and TOH Head of Anatomic Pathology, Principal Investigator for Ottawa-site Ontario Tumour Bank (OTB), and Regional Cancer Pathology Lead for Cancer Care Ontario (CCO) in Ottawa.
His main research interest is to explore the role of nAchRs in cancer pathogenesis and modulation of these receptors for possible therapeutic targets. He has authored or co-authored 200+ original publication and abstracts in addition to recipient many research grants. He has served as the Chair of Canadian Society of Cytopathology and is Editorial board member of Canadian Journal of Pathology. He is also an active member of many provincial and national advisory boards and committees including CCO Thoracic Cancer Advisory Board and Canadian (C-PAC) Elimination of Cervical Cancer Implementation group.